2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of <i>Plasmodium falciparum</i>.

Amrane, Dyhia; Arnold, Christophe-Sébastien; Hutter, Sébastien; Sanz-Serrano, Julen; Collia, Miguel; Azqueta, Amaya; Paloque, Lucie; Cohen, Anita; Amanzougaghene, Nadia; Tajeri, Shahin; Franetich, Jean-François; Mazier, Dominique; Benoit-Vical, Françoise; Verhaeghe, Pierre; Azas, Nadine; Vanelle, Patrice; Botté, Cyrille; Primas, Nicolas

2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of Plasmodium falciparum.

Amrane, Dyhia; Arnold, Christophe-Sébastien; Hutter, Sébastien; Sanz-Serrano, Julen; Collia, Miguel; Azqueta, Amaya; Paloque, Lucie; Cohen, Anita; Amanzougaghene, Nadia; Tajeri, Shahin; Franetich, Jean-François; Mazier, Dominique; Benoit-Vical, Françoise; Verhaeghe, Pierre; Azas, Nadine; Vanelle, Patrice; Botté, Cyrille; Primas, Nicolas.

Afiliação

Amrane D; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, CEDEX 05, 13385 Marseille, France.
Arnold CS; ApicoLipid Team, Institute for Advanced Biosciences, Université Grenoble Alpes, 38700 La Tronche, France.
Hutter S; Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, CEDEX 05, 13005 Marseille, France.
Sanz-Serrano J; Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain.
Collia M; Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain.
Azqueta A; Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain.
Paloque L; Navarra Institute for Health Research, IdiSNA, Irunlarrea 3, 31008 Pamplona, Spain.
Cohen A; LCC-CNRS, Université de Toulouse, CNRS UPR8241, UPS, 31400 Toulouse, France.
Amanzougaghene N; MAAP, New Antimalarial Molecules and Pharmacological Approaches, MAAP, Inserm ERL 1289, 31400 Toulouse, France.
Tajeri S; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31400 Toulouse, France.
Franetich JF; Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, CEDEX 05, 13005 Marseille, France.
Mazier D; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.
Benoit-Vical F; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.
Verhaeghe P; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.
Azas N; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.
Vanelle P; LCC-CNRS, Université de Toulouse, CNRS UPR8241, UPS, 31400 Toulouse, France.
Botté C; MAAP, New Antimalarial Molecules and Pharmacological Approaches, MAAP, Inserm ERL 1289, 31400 Toulouse, France.
Primas N; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31400 Toulouse, France.